{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T08:41:19Z","timestamp":1773218479562,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.hlc.2023.12.008","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T06:15:11Z","timestamp":1707459311000},"page":"376-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Impact of Diabetes on Haemodynamic and Cardiometabolic Responses in Heart Failure With Preserved Ejection Fraction"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2728-7526","authenticated-orcid":false,"given":"Emilia","family":"Nan Tie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0146-6588","authenticated-orcid":false,"given":"Shane","family":"Nanayakkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Vizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9283-1551","authenticated-orcid":false,"given":"Justin","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4058-0372","authenticated-orcid":false,"given":"David M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2023.12.008_bib1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hlc.2023.12.008_bib2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.116.024593","volume":"135","author":"Kristensen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2023.12.008_bib3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10557-017-6754-x","article-title":"Prevalence of prediabetes and undiagnosed diabetes in patients with HFpEF and HFrEF and associated clinical outcomes","volume":"31","author":"Kristensen","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.hlc.2023.12.008_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2016.07.025","article-title":"Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: findings from Get with the Guidelines-Heart Failure registry","volume":"182","author":"Echouffo-Tcheugui","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.hlc.2023.12.008_bib5","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2023.12.008_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ehj.2004.01.010","article-title":"Impact of diabetes mellitus on long-term survival in patients with congestive heart failure","volume":"25","author":"De Groote","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2023.12.008_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12933-021-01242-5","article-title":"Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort","volume":"20","author":"Lejeune","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.hlc.2023.12.008_bib8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jacc.2018.11.033","article-title":"Heart failure with preserved ejection fraction and diabetes: JACC state-of-the-art review","volume":"73","author":"McHugh","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2023.12.008_bib9","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1161\/CIR.0000000000000691","article-title":"Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update","volume":"140","author":"Dunlay","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2023.12.008_bib10","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2023.12.008_bib11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction","volume":"3","author":"Borlaug","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hlc.2023.12.008_bib12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2010.04.040","article-title":"Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction","volume":"56","author":"Maeder","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2023.12.008_bib13","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/eurheartj\/ehy331","article-title":"Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease","volume":"39","author":"Gorter","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2023.12.008_bib14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardfail.2014.05.003","article-title":"Outcomes in World Health Organization group II pulmonary hypertension: mortality and readmission trends with systolic and preserved ejection fraction-induced pulmonary hypertension","volume":"20","author":"Salamon","year":"2014","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.hlc.2023.12.008_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.amjcard.2017.11.040","article-title":"Diabetes mellitus and right ventricular dysfunction in heart failure with preserved ejection fraction","volume":"121","author":"Gorter","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hlc.2023.12.008_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/CIRCRESAHA.118.314555","article-title":"Metabolic syndrome exacerbates pulmonary hypertension due to left heart disease","volume":"125","author":"Ranchoux","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2023.12.008_bib17","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/CIRCULATIONAHA.106.663120","article-title":"Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation","volume":"115","author":"Hansmann","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2023.12.008_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"van Heerebeek","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2023.12.008_bib19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jchf.2014.08.004","article-title":"Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure","volume":"3","author":"Dei Cas","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hlc.2023.12.008_bib20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jacc.2014.05.030","article-title":"Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study","volume":"64","author":"Lindman","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2023.12.008_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0026-0495(92)90185-D","article-title":"Insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin","volume":"41","author":"Lovejoy","year":"1992","journal-title":"Metabolism"},{"key":"10.1016\/j.hlc.2023.12.008_bib22","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/ije\/dyq126","article-title":"Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study","volume":"39","author":"Crawford","year":"2010","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.hlc.2023.12.008_bib23","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1113\/JP279963","article-title":"The anaerobic threshold: 50+ years of controversy","volume":"599","author":"Poole","year":"2021","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.hlc.2023.12.008_bib24","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1113\/jphysiol.2009.178350","article-title":"Cell-cell and intracellular lactate shuttles","volume":"587","author":"Brooks","year":"2009","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.hlc.2023.12.008_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.cardfail.2020.07.010","article-title":"Metabolomic profile in HFpEF vs HFrEF patients","volume":"26","author":"Hage","year":"2020","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.hlc.2023.12.008_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A\u00a0novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2023.12.008_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91546-z","article-title":"Decoding empagliflozin's molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence","volume":"11","author":"Bayes-Genis","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.hlc.2023.12.008_bib28","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/CIRCULATIONAHA.120.052503","article-title":"Empagliflozin effects on pulmonary artery pressure in patients with heart failure: results from the EMBRACE-HF trial","volume":"143","author":"Nassif","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2023.12.008_bib29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12933-020-01100-w","article-title":"Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysis","volume":"19","author":"Halabi","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.hlc.2023.12.008_bib30","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1161\/CIRCULATIONAHA.108.798561","article-title":"Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase","volume":"119","author":"Sasaki","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2023.12.008_bib31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1210\/jc.2011-1508","article-title":"Exenatide exerts a potent antiinflammatory effect","volume":"97","author":"Chaudhuri","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2023.12.008_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrneph.2017.123","article-title":"GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes","volume":"13","author":"Muskiet","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.hlc.2023.12.008_bib33","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.120.045888","article-title":"Glucagon-like peptide 1 receptor agonists and heart failure: the need for further evidence generation and practice guidelines optimization","volume":"142","author":"Khan","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2023.12.008_bib34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fendo.2017.00160","article-title":"Targeting obesity and diabetes to treat heart failure with preserved ejection fraction","volume":"8","author":"Altara","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.hlc.2023.12.008_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007555","article-title":"Current limitations of invasive exercise hemodynamics for the diagnosis of heart failure with preserved ejection fraction","volume":"14","author":"Baratto","year":"2021","journal-title":"Circ Heart Fail"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950623044682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950623044682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T01:10:14Z","timestamp":1729127414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950623044682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1443950623044682"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2023.12.008","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Diabetes on Haemodynamic and Cardiometabolic Responses in Heart Failure With Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2023.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}